chr5-149960980-G-A
Position:
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PVS1_ModeratePM2PP5_Moderate
The NM_000112.4(SLC26A2):c.-26+1G>A variant causes a splice donor, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000656 in 152,386 control chromosomes in the GnomAD database, with no homozygous occurrence. 3/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Likely pathogenic (★).
Frequency
Genomes: 𝑓 0.0000066 ( 0 hom., cov: 33)
Consequence
SLC26A2
NM_000112.4 splice_donor, intron
NM_000112.4 splice_donor, intron
Scores
2
Splicing: ADA: 1.000
2
Clinical Significance
Conservation
PhyloP100: 2.38
Genes affected
SLC26A2 (HGNC:10994): (solute carrier family 26 member 2) The diastrophic dysplasia sulfate transporter is a transmembrane glycoprotein implicated in the pathogenesis of several human chondrodysplasias. It apparently is critical in cartilage for sulfation of proteoglycans and matrix organization. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
PVS1
Splicing +-2 bp (donor or acceptor) variant, product NOT destroyed by NMD, known LOF gene, truncates exone, which is 0.09954955 fraction of the gene. No cryptic splice site detected. Exon removal is inframe change.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 5-149960980-G-A is Pathogenic according to our data. Variant chr5-149960980-G-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1803123.Status of the report is criteria_provided_single_submitter, 1 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC26A2 | NM_000112.4 | c.-26+1G>A | splice_donor_variant, intron_variant | ENST00000286298.5 | NP_000103.2 | |||
SLC26A2 | XM_017009191.3 | c.-26+1G>A | splice_donor_variant, intron_variant | XP_016864680.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC26A2 | ENST00000286298.5 | c.-26+1G>A | splice_donor_variant, intron_variant | 1 | NM_000112.4 | ENSP00000286298.4 | ||||
SLC26A2 | ENST00000433184.1 | c.-306+1G>A | splice_donor_variant, intron_variant | 4 | ENSP00000405496.1 | |||||
SLC26A2 | ENST00000690410.1 | n.207+1G>A | splice_donor_variant, intron_variant |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152268Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
1
AN:
152268
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD4 exome Cov.: 0
GnomAD4 exome
Cov.:
0
GnomAD4 genome AF: 0.00000656 AC: 1AN: 152386Hom.: 0 Cov.: 33 AF XY: 0.0000134 AC XY: 1AN XY: 74518
GnomAD4 genome
AF:
AC:
1
AN:
152386
Hom.:
Cov.:
33
AF XY:
AC XY:
1
AN XY:
74518
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Likely pathogenic
Submissions summary: Pathogenic:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
Achondrogenesis, type IB Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Genetics and Molecular Pathology, SA Pathology | May 25, 2020 | PVS1, PM2 The SLC26A2 c.-26+1G>T variant is a single nucleotide change from a guanine to a thymine at the canonical splice donor site in the 5’UTR. The variant has not been described in the literature to date. A Finnish founder mutation has been described at the adjacent c.-26+2T>C position of the same canonical splice site which is considered pathogenic and for which RNA studies have shown aberrant splicing and reduced mRNA levels (PMID: 10482955; PMID: 11241838). Individuals homozygous for the c.-26+2T>C variant tend to present with a phenotype that is intermediate in severity and diastrophic dysplasia (MIM 222600). Phenotypic differences have been observed between individuals with the same SLC26A2 variant (PMID: 32295296). The c.-26+1G>T variant observed in this patient has not been reported in dbSNP and is absent from population databases (PM2). The variant has not been reported in the ClinVar or HGMD disease databases. Computational splice predictions and its location adjacent to the Finnish founder mutation within the same canonical splice site suggest that the variant may alter splicing and result in severely reduced mRNA levels (PVS1). The variant is located in a predicted region of homozygosity on chromosome 5. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Pathogenic
dbscSNV1_RF
Pathogenic
SpliceAI score (max)
Details are displayed if max score is > 0.2
DS_DL_spliceai
Position offset: -1
Find out detailed SpliceAI scores and Pangolin per-transcript scores at